SLC2A1 and ovarian carcinoma: Overexpression of GLUT1 and/or GLUT3 is linked to poor survival outcomes across a variety of investigated cancer types, including breast carcinoma, lung adenocarcinoma, colorectal carcinoma, ovarian carcinoma, squamous cell carcinoma, and glioblastoma [15, 22, 35, 36].